Madrigal Pharmaceuticals Overview
Madrigal Pharmaceuticals Target Price
Analysts' 12-month price predictions for MDGL.
Get informed when a big investor buys or sells
+ FollowShare Price
$488.15
Average Target Price
$645.33
32.2% upside
32.2% upside3 analysts in the last 4 months
High: $709 | Low: $578
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-13 | Truist Financial | $709 | 45.2% upside |  |
| 2026-05-07 | Evercore ISI | $649 | 33% upside | |
| 2026-05-07 | Canaccord Genuity | $578 | 18.4% upside | |
| 2026-01-27 | Barclays | $964 | 97.5% upside | |
| 2026-01-14 | Goldman SachsAndrea Tan | $571 | 17% upside | |
| 2026-01-06 | Wolfe ResearchAndy Chen | $579 | 18.6% upside | |
| 2025-12-19 | Piper SandlerYasmeen Rahimi | $900 | 84.4% upside | |
| 2025-12-19 | UBS | $900 | 84.4% upside | |
| 2025-11-21 | H.C. Wainwright | $620 | 27% upside | |
| 2025-11-20 | OppenheimerJay Olson | $650 | 33.2% upside | |
| 2025-11-19 | Truist Financial | $640 | 31.1% upside | |
| 2025-11-05 | JMP Securities | $527 | 8% upside | |
| 2025-10-15 | Piper Sandler | $540 | 10.6% upside | |
| 2025-10-14 | Truist Financial | $580 | 18.8% upside | |
| 2025-10-10 | OppenheimerJay Olson | $590 | 20.9% upside | |
| 2025-05-02 | Canaccord GenuityEdward Nash | $420 |  14% downside | |
| 2024-05-29 | Piper SandlerYasmeen Rahimi | $336 | 31.2% downside | |
| 2024-05-09 | H.C. WainwrightEd Acre | $390 | 20.1% downside | |
| 2024-03-19 | Evercore ISILiisa Bayko | $405 | 17% downside | |
| 2024-03-15 | UBSEliana Merle | $410 | 16% downside | |
| 2024-03-15 | JefferiesAkash Tewari | $400 | 18.1% downside | |
| 2024-03-15 | H.C. WainwrightEd Acre | $425 | 12.9% downside | |
| 2024-03-15 | JMP SecuritiesJonathan Wolleben | $397 | 18.7% downside | |
| 2024-03-15 | B.Riley FinancialMayank Mamtani | $270 | 44.7% downside | |
| 2023-01-05 | JMP Securities | $390 | 20.1% downside | |
| 2022-12-21 | UBS | $337 | 31% downside | |
| 2022-12-20 | H.C. Wainwright | $225 | 53.9% downside | |
| 2022-12-20 | Oppenheimer | $250 | 48.8% downside | |
| 2022-12-20 | Goldman Sachs | $375 | 23.2% downside | |
| 2022-12-20 | JMP Securities | $312 | 36.1% downside | |
| 2022-12-20 | Leerink Partners | $315 | 35.5% downside | |
| 2021-08-06 | BMO CapitalMatthew Luchini | $111 | 77.3% downside | |
| 2021-05-20 | Goldman SachsAndrea Tan | $195 | 60.1% downside | |
| 2021-05-06 | Wells FargoDerek Archila | $130 | 73.4% downside | |